01672 ASCLETIS-B
- 1.550
- +0.020+1.31%
ASCLETIS-B News
Repurchase summary on November 27 | tencent, aia and others have repurchased shares, with tencent spending 0.704 billion HKD.
According to the documents disclosed by hkex on November 28, $tencent (00700.HK)$, $aia (01299.HK)$ and others repurchased shares. ① $tencent (00700.HK)$ repurchased 1.77 million ordinary shares on November 27, involving an amount of 0.704 billion Hong Kong dollars, with a repurchase price ranging from 405.8 Hong Kong dollars to 392.2 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities has reached 0.193 billion shares, accounting for 2.054% of the number of shares issued at the time the ordinary resolution was passed. ② $aia (01299.HK)$
On November 27, Gilai Pharmaceuticals-B (01672.HK) spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares.
On November 27, Geloan Hui reported that Gilead Sciences-B (01672.HK) announced it spent HKD 0.993 million to repurchase 0.6 million shares.
Repurchase summary on November 26 | tencent, hsbc holdings and others have repurchased shares, among which tencent spent 0.703 billion HKD.
According to documents disclosed by hkex on November 27, tencent holdings (00700.HK), hsbc holdings (00005.HK), and others repurchased shares. ① Tencent Holdings (00700.HK) repurchased 1.78 million shares of common stock on November 26, involving an amount of 0.703 billion Hong Kong dollars, with a repurchase price per share ranging from 399 Hong Kong dollars to 392.2 Hong Kong dollars. Since the repurchase authorization resolution, the total number of repurchased securities is 0.192 billion shares, accounting for 2.035% of the number of issued shares when the ordinary resolution was passed. ② Hsbc Holdings (00005.HK) on 1
This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?
According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.
GL Events-B (01672.HK) spent 0.336 million Hong Kong dollars to repurchase 0.2 million shares on November 26th.
Glory pharmaceutical-B(01672.HK) announced on November 26th that it spent 0.336 million Hong Kong dollars to buy back 0.2 million shares on November 26th.
November 25th buyback collective | Tencent Holdings, AIA and others have successively repurchased, with Tencent Holdings spending 0.702 billion Hong Kong dollars.
According to the hkex disclosure on November 26, tencent (00700.HK), aia (01299.HK), and other companies repurchased shares. ① Tencent (00700.HK) repurchased 1.77 million shares of common stock on November 25, involving an amount of 0.702 billion Hong Kong dollars, with a repurchase price per share ranging from 402 Hong Kong dollars to 394 Hong Kong dollars. Since the repurchase authorization resolution, the total number of repurchased securities is 0.19 billion shares, accounting for 2.016% of the number of shares issued when the ordinary resolution was passed. ② AIA (01299.HK) on November 2
China Resources Pharmaceutical Group-B (01672.HK) spent 0.513 million Hong Kong dollars to repurchase 0.3 million shares on November 25.
On November 25, Gelonghui announced that Sihuan Pharmaceutical-B (01672.HK) spent 0.513 million Hong Kong dollars to repurchase 0.3 million shares.
Many innovative drugs stocks in Hong Kong suddenly soared!
On the morning of November 25, the hang seng index fell slightly, while the Hong Kong stock market's biomedical sector performed well. Notably, several biomedical companies saw their stock prices rise significantly due to recent news of major collaboration advancements.
Share repurchase on November 22 | tencent, aia, and others have repurchased, among which tencent spent 0.702 billion HKD.
According to documents disclosed by hkex on November 25, tencent repurchased shares, along with aia. Tencent repurchased 1.73 million shares of common stock on November 22, involving 0.702 billion Hong Kong dollars, with a repurchase price ranging from 412.2 Hong Kong dollars to 399.8 Hong Kong dollars per share. Since the repurchase authorization resolution, the total number of repurchased securities is 0.188 billion shares, accounting for 1.997% of the number of issued shares at the time of the ordinary resolution. Aia
CSPC Pharmaceutical Group Limited - B (01672) spent 1.0154 million Hong Kong dollars to repurchase 0.575 million shares on November 22nd.
Gelesis Pharmaceutical-B (01672) announced that on November 22, 2024, the company invested 101.54 million...
On November 21, buyback gatherings | Tencent, AIA and others have successively repurchased, with Tencent spending 0.704 billion Hong Kong dollars.
According to hkex's disclosure on November 22nd, tencent repurchased shares, including aia. Tencent repurchased 1.72 million ordinary shares on November 21, involving 0.704 billion Hong Kong dollars, with a repurchase price ranging from 411.2 Hong Kong dollars to 407.4 Hong Kong dollars per share. Since the repurchase authorization resolution, the total number of repurchased securities is 0.186 billion shares, accounting for 1.979% of the number of shares issued when the ordinary resolution was passed. Aia also repurchased shares.
On November 21, Gilead Sciences-B (01672.HK) spent HKD 0.128 million to repurchase 0.076 million shares.
Galien Pharmaceutical-B (01672.HK) announced on November 21 that it will spend 0.128 million Hong Kong dollars to repurchase 0.076 million shares on November 21, 2024, at a repurchase price of 1.67-1.7 Hong Kong dollars per share.
November 20th buyback collection | tencent, aia insurance and others have successively repurchased, with tencent spending 0.701 billion Hong Kong dollars.
According to documents disclosed by hkex on November 21, tencent (00700.HK), aia (01299.HK), among others, repurchased shares. ① Tencent (00700.HK) repurchased 1.71 million ordinary shares on November 20, involving 0.701 billion Hong Kong dollars, with a repurchase price ranging from 413.4 Hong Kong dollars to 406.6 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.185 billion shares, accounting for 1.961% of the number of issued shares at the time of the ordinary resolution passing. ② AIA (01299.HK)
China Resources Pharmaceutical Group - B (01672.HK) spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares on November 20.
Glory Pharmaceuticals-B (01672.HK) announced on November 20th that it spent 0.499 million Hong Kong dollars to repurchase 0.3 million shares.
November 19 stock buyback collection | tencent, aia and others have carried out buybacks, among which tencent spent 0.703 billion Hong Kong dollars.
According to the document disclosed by hkex on November 20, tencent (00700.HK), aia (01299.HK), and others repurchased shares. ① tencent (00700.HK) repurchased 1.73 million ordinary shares on November 19, involving an amount of 0.703 billion HKD, with a repurchase price between 409 HKD and 403.4 HKD per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.183 billion shares, accounting for 1.943% of the number of shares issued at the time the ordinary resolution was passed. ② aia (01299.HK) repurchased 1
Glory Pharmaceutical-B (01672.HK) spent 0.5022 million Hong Kong dollars on November 19th to repurchase 0.3 million shares.
Galee Pharmaceutical-B (01672.HK) announced on November 19th that it will spend 0.5022 million Hong Kong dollars to repurchase 0.3 million shares on November 19, 2024, at a repurchase price of 1.65-1.68 Hong Kong dollars per share.
On November 19, 2023, Geely Pharmaceutical-B (01672) spent 0.502 million HKD to repurchase 0.3 million shares.
Songlei Pharmaceutical-B (01672) announced that it will spend 0.502 million Hong Kong dollars to repurchase on November 19, 2024...
November 18th Buyback Collection | Tencent Holdings, AIA and others have successively bought back, with Tencent Holdings spending 0.703 billion Hong Kong dollars.
According to documents disclosed by hkex on November 19, $tencent (00700.HK)$, $aia (01299.HK)$, and others repurchased shares. ① $tencent (00700.HK)$ repurchased 1.73 million ordinary shares on November 18, involving an amount of 0.703 billion HKD, with a repurchase price ranging from 412.8 HKD to 401.8 HKD per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities has reached 0.181 billion shares, accounting for 1.924% of the number of shares issued at the time the ordinary resolution was passed. ② $aia (01299.HK)$.
On November 18, Singlomd Pharmaceuticals-B (01672) spent 0.8311 million Hong Kong dollars to repurchase 0.5 million shares.
BeiGene, Ltd. (01672) announced that on November 18, 2024, the company invested 0.8311 million...
November 15 repurchase collection | tencent, hsbc holdings and others have repurchased, among which tencent spent 0.704 billion Hong Kong dollars.
According to the disclosure documents released by hkex on November 18th, tencent Holdings (00700.HK) and hsbc Holdings (00005.HK) repurchased shares. ① Tencent Holdings (00700.HK) repurchased 1.75 million ordinary shares on November 15th, involving an amount of 0.704 billion Hong Kong dollars, with the repurchase price per share ranging from 406.8 Hong Kong dollars to 399.2 Hong Kong dollars. Since the repurchase authorization resolution, the cumulative number of securities repurchased is 0.18 billion shares, accounting for 1.906% of the number of shares issued when the ordinary resolution was passed. ② Hsbc Holdings (00005.HK) on
Analysis
Price Target
No Data
No Data